Semaglutide is approved as Wegovy (chronic weight management) and Ozempic (type 2 diabetes), both from Novo Nordisk
Clinical monitoring of 847 women using AOD 9604 for up to 6 months showed no significant changes in liver function, kidney markers, or cardiovascular parameters
The current injectable GLP-1 therapies, despite their efficacy, reach only a small fraction of the eligible population due to cost, injection barriers, manufacturing constraints, and supply limitations
Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
You will typically start on the 1.5 mg dose and titrate up over time
Subscribe for exclusive offers and product updates